Trupanion’s (TRUP) Outperform Rating Reaffirmed at Cowen

Trupanion (NASDAQ:TRUP)‘s stock had its “outperform” rating reiterated by analysts at Cowen in a report released on Wednesday, The Fly reports. They currently have a $38.00 price objective on the financial services provider’s stock, up from their previous price objective of $32.00. Cowen’s target price would suggest a potential upside of 21.52% from the company’s previous close.

A number of other brokerages have also weighed in on TRUP. BidaskClub raised Trupanion from a “hold” rating to a “buy” rating in a research note on Monday, December 18th. Northland Securities reissued a “buy” rating and set a $38.00 price target on shares of Trupanion in a research note on Thursday, February 8th. Stifel Nicolaus increased their price target on Trupanion from $33.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday. Zacks Investment Research raised Trupanion from a “hold” rating to a “buy” rating and set a $37.00 price target on the stock in a research note on Wednesday, November 8th. Finally, CL King began coverage on Trupanion in a research note on Tuesday, November 21st. They set a “neutral” rating on the stock. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $34.67.

Shares of Trupanion (NASDAQ:TRUP) opened at $31.27 on Wednesday. Trupanion has a 52 week low of $13.88 and a 52 week high of $36.88. The company has a quick ratio of 1.87, a current ratio of 1.87 and a debt-to-equity ratio of 0.15. The stock has a market capitalization of $935.74, a P/E ratio of -347.41 and a beta of 0.34.

In related news, insider Asher Bearman sold 4,039 shares of the stock in a transaction on Tuesday, November 21st. The stock was sold at an average price of $28.40, for a total value of $114,707.60. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Ian Moffat sold 7,000 shares of the stock in a transaction on Monday, November 27th. The stock was sold at an average price of $30.06, for a total value of $210,420.00. Following the completion of the transaction, the chief operating officer now directly owns 7,000 shares in the company, valued at $210,420. The disclosure for this sale can be found here. In the last three months, insiders have sold 25,039 shares of company stock worth $775,403. Corporate insiders own 31.24% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of TRUP. Schwab Charles Investment Management Inc. raised its position in shares of Trupanion by 75.1% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 37,300 shares of the financial services provider’s stock worth $835,000 after buying an additional 16,000 shares during the period. Bank of New York Mellon Corp raised its position in shares of Trupanion by 31.2% in the 2nd quarter. Bank of New York Mellon Corp now owns 74,800 shares of the financial services provider’s stock worth $1,674,000 after buying an additional 17,809 shares during the period. Swiss National Bank raised its position in shares of Trupanion by 21.7% in the 2nd quarter. Swiss National Bank now owns 31,910 shares of the financial services provider’s stock worth $714,000 after buying an additional 5,700 shares during the period. Wells Fargo & Company MN raised its position in shares of Trupanion by 13.5% in the 2nd quarter. Wells Fargo & Company MN now owns 11,261 shares of the financial services provider’s stock worth $252,000 after buying an additional 1,342 shares during the period. Finally, Alliancebernstein L.P. raised its position in shares of Trupanion by 11.4% in the 2nd quarter. Alliancebernstein L.P. now owns 18,600 shares of the financial services provider’s stock worth $416,000 after buying an additional 1,900 shares during the period. 63.79% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This story was first posted by American Banking News and is owned by of American Banking News. If you are viewing this story on another site, it was stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this story can be read at https://www.americanbankingnews.com/2018/02/14/trupanions-trup-outperform-rating-reaffirmed-at-cowen.html.

About Trupanion

Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.

The Fly

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply